Bioventus to Present at the Canaccord Genuity Musculoskeletal Conference
Bioventus (Nasdaq: BVS) announced that CEO Ken Reali will participate in a fireside chat at the Canaccord Genuity Musculoskeletal Conference on March 22, 2022, at 11:00 a.m. ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Bioventus (Nasdaq: BVS) announced that CEO Ken Reali will participate in a fireside chat at the Canaccord Genuity Musculoskeletal Conference on March 22, 2022, at 11:00 a.m. ET. A live webcast will be available on the Company’s website under the 'Investors' section, with a replay accessible after the event. Bioventus is recognized for delivering innovative, cost-effective solutions that promote healing and enhance patient quality of life. The Company focuses on pain treatment, restorative therapies, and surgical solutions.
Details
News Market Reaction – BVS
The recorded move for BVS in the trading session of this news was +2.30%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
DURHAM, N.C., March 16, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Ken Reali, chief executive officer, will participate in a fireside chat at the Canaccord Genuity Musculoskeletal Conference on Tuesday, March 22, 2022, at 11:00 a.m. ET.
A live webcast of the fireside chat will be available on the “Investors” section of the Company’s website at www.bioventus.com and will be available for replay on that site following the event.
About Bioventus
Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations for Active Healing from Bioventus include offerings for pain treatment, restorative therapies and surgical solutions. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide. For more information, visit www.bioventus.com, and follow the Company on LinkedIn and Twitter. Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC.
Media Contact:
Jamica Whitaker
919-666-5770
jamica.whitaker@bioventus.com
Investor Contact:
Dave Crawford
919-474-6787
dave.crawford@bioventus.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.